Cohance Lifesciences promoter sells 8.9% stake for Rs.3,094-Cr in bulk deal

Promoter Jusmiral Holdings has offloaded an 8.9% stake (3.41 lakh shares) in Hyderabad-based Cohance Lifesciences , a contract development and manufacturing organisation, for INR 3,093.8 crore (at INR 906 per share) via open market transactions on September 18. The promoters' shareholding in the company was 66.41% as of June 2025.HDFC Mutual Fund and SBI Mutual Fund acquired some of those Cohance shares, buying 37.17 lakh shares (0.97% stake) at INR 906 per share, amounting to INR 336.8 crore, and 26.83 lakh shares (0.7%) at INR 905.71 per share for INR 243 crore, respectively.Cohance Lifesciences is a Contract Development and Manufacturing Organization (CDMO) that provides integrated services for the development and manufacturing of New Chemical Entity (NCE)-based intermediates, Active Pharmaceutical Ingredients (APIs), specialty chemicals, and formulations for global pharmaceutical, biotechnology, and chemical companies.